Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ViroCell Biologics

ViroCell Manufactured a GMP Lentiviral Vector for UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer
From ViroCell Biologics
Via Business Wire
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
From ViroCell Biologics
Via Business Wire
ViroCell Biologics Expands U.S. Business Development Team With Two New Appointments
From ViroCell Biologics
Via Business Wire
ViroCell Biologics to Host Panel Event at 2024 Cell & Gene Meeting on the Mesa
From ViroCell Biologics
Via Business Wire
ViroCell Biologics Completes Oversubscribed Financing
From ViroCell Biologics
Via Business Wire
ViroCell Biologics Signs Master Services Agreement With Prominent NCI-Designated Cancer Center
From ViroCell Biologics
Via Business Wire
ViroCell to present at 2024 Cell & Gene Meeting on the Med
From ViroCell Biologics
Via Business Wire
ViroCell and Great Ormond Street Hospital Poised to Unlock Clinical Trial ‘Backlog’ Following MHRA Manufacturing Approval
From ViroCell Biologics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.